knowledge -WSS

knowledge

author：focus 2025-09-29 01:37:52 - browse：52654

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Democrats decry new health bill for going easy on private equity

WSS

The world needs the new pandemic treaty

Lawsuit challenges CMS nursing home minimum staffing rule

Will the FTC rein in IQVIA's health data empire?

UHS says company favors patients whose insurance pays more

The battle over 'scope creep' and who gets to be called 'doctor'

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

leisure time

knowledge

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Cancer drug shortages should be causing more outrage

Search called off for baby washed away in Pennsylvania flash flood

What does generative AI mean for health care? We asked experts

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Affirmative action in medical school literally saved lives

UHS says company favors patients whose insurance pays more

In Memoriam: Notable people who died in 2023

Congress: Prevent baby formula shortages by passing a new bill

Wikipedia

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Device maker Teleflex to acquire urology company for $600M

The battle over 'scope creep' and who gets to be called 'doctor'

Device maker Teleflex to acquire urology company for $600M

UHS says company favors patients whose insurance pays more

hotspot

hotspot

focus

knowledge